Submitted by Anonymous (not verified) on 28 January 2026 - 12:55
Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 35, Status: Authorised
Source: